Go Pro
→ They're not buying gold. They're buying this. (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$86.75
+1.8%		$95.10
$69.51
▼
$110.68
$110.81B0.68.22 million shs296,677 shs
Humana Inc. stock logo
HUM
Humana
$381.71
+0.5%		$385.40
$163.11
▼
$428.88
$45.90B0.741.64 million shs13,349 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
-0.75%+0.22%-12.54%-18.70%+10.81%
Humana Inc. stock logo
HUM
Humana
-0.89%-0.48%-3.87%-4.31%+53.64%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$86.75
+1.8%		$95.10
$69.51
▼
$110.68
$110.81B0.68.22 million shs296,677 shs
Humana Inc. stock logo
HUM
Humana
$381.71
+0.5%		$385.40
$163.11
▼
$428.88
$45.90B0.741.64 million shs13,349 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
-0.75%+0.22%-12.54%-18.70%+10.81%
Humana Inc. stock logo
HUM
Humana
-0.89%-0.48%-3.87%-4.31%+53.64%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.96
Moderate Buy$107.2423.62% Upside
Humana Inc. stock logo
HUM
Humana
2.47
Hold$408.617.05% Upside

Current Analyst Ratings Breakdown

Latest HUM and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/1/2026
CVS Health Corporation stock logo
CVS
CVS Health
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/25/2026
Humana Inc. stock logo
HUM
Humana
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$407.00 ➝ $515.00
9/22/2026
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/9/2026
CVS Health Corporation stock logo
CVS
CVS Health
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$112.00
9/9/2026
CVS Health Corporation stock logo
CVS
CVS Health
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$112.00
9/9/2026
CVS Health Corporation stock logo
CVS
CVS Health
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$112.00
9/4/2026
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/3/2026
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$126.00 ➝ $118.00
8/26/2026
CVS Health Corporation stock logo
CVS
CVS Health
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/24/2026
Humana Inc. stock logo
HUM
Humana
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$450.00
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$402.07B0.28$15.09 per share5.75$59.38 per share1.46
Humana Inc. stock logo
HUM
Humana
$129.66B0.35$24.07 per share15.86$147.47 per share2.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$3.7822.9210.190.831.18%13.12%3.95%11/4/2026 (Estimated)
Humana Inc. stock logo
HUM
Humana
$1.19B$10.5736.1624.822.350.88%11.20%3.94%11/6/2026 (Estimated)

Latest HUM and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
CVS Health Corporation stock logo
CVS
CVS Health
$1.87$2.58+$0.71$2.31$100.03 billion$106.10 billion
7/29/2026Q2 2026
Humana Inc. stock logo
HUM
Humana
$7.27$7.61+$0.34$5.73$40.58 billion$40.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.07%+5.87%70.37%4 Years
Humana Inc. stock logo
HUM
Humana
$3.540.93%+7.20%33.49%N/A

Latest HUM and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/1/2026
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.88%10/30/202610/30/202611/27/2026
9/30/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.1%10/22/202610/22/202611/2/2026
7/10/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66502.49%7/23/20267/23/20268/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.74
0.87
0.66
Humana Inc. stock logo
HUM
Humana
0.62
1.74
1.74

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Humana Inc. stock logo
HUM
Humana
92.38%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Humana Inc. stock logo
HUM
Humana
0.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Humana Inc. stock logo
HUM
Humana
67,060120.08 million119.84 millionOptionable

Recent News About These Companies

Zacks Research Issues Negative Outlook for Humana Earnings
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-zacks-research-issues-negative-outlook-for-humana-earnings-2026-10-02/
Humana Names New Head of Assistans Amid Ambea Takeover
October 2 at 3:50 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/humana-names-new-head-of-assistans-amid-ambea-takeover?utm_source=marketbeat.com&utm_medium=referral
Humana Expands Medicare Advantage Options For 2027; Stock Down
October 1 at 7:41 PM  |  rttnews.comhttps://www.rttnews.com/3695891/humana-expands-medicare-advantage-options-for-2027-stock-down.aspx
Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Got Their Plan-Change Letters Weeks Earlier. Wall Street Got the Numbers in July
October 1 at 3:10 PM  |  247wallst.comhttps://247wallst.com/personal-finance/2026/10/01/humana-reports-third-quarter-earnings-nov-6-in-the-middle-of-open-enrollment-members-got-their-plan-change-letters-weeks-earlier-wall-street-got-the-numbers-in-july/
Ambea Gains Control of Humana and Moves to Full Takeover and Delisting
October 1 at 10:51 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ambea-gains-control-of-humana-and-moves-to-full-takeover-and-delisting?utm_source=marketbeat.com&utm_medium=referral
Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027
October 1 at 9:39 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/humana-maintains-affordable-medicare-advantage-110000010.html
What is Zacks Research's Estimate for Humana Q3 Earnings?
October 1 at 6:12 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073647
Zacks Research Has Optimistic Opinion of Humana Q3 Earnings
October 1 at 6:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-zacks-research-has-optimistic-opinion-of-humana-q3-earnings-2026-10-01/
Envestnet Asset Management Inc. Increases Position in Humana Inc. $HUM
October 1 at 3:04 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-envestnet-asset-management-inc-increases-position-in-humana-inc-hum-2026-10-01/
Research Analysts Set Expectations for Humana Q1 Earnings
September 30 at 7:41 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-research-analysts-set-expectations-for-humana-q1-earnings-2026-09-30/
Humana 'Extra Help' call alarms Medicare recipient, and replies warn Social Security doesn't call
September 29 at 2:18 PM  |  msn.comhttps://www.msn.com/en-us/news/other/humana-extra-help-call-alarms-medicare-recipient-and-replies-warn-social-security-doesnt-call/ar-AA2datCi
Humana Medicare Advantage patient's $35 cortisone shot turns into $319 after billing switch
September 29 at 1:06 AM  |  msn.comhttps://www.msn.com/en-us/health/general/humana-medicare-advantage-patient-s-35-cortisone-shot-turns-into-319-after-billing-switch/ar-AA2d9Vrb
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
September 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-humana-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302891129.html
Barclays upgrades Humana Inc. - depositary receipt to overweight from equal-weight
September 27, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/barclays-upgrades-humana-inc-depositary-receipt-to-overweight-from-equal-weight/ar-AA2d3Q6s
Humana (NYSE:HUM) Rating Lowered to "Hold" at Wall Street Zen
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31053701
Humana (NYSE:HUM) Rating Lowered to Hold at Wall Street Zen
September 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-humana-nyse-hum-rating-lowered-to-hold-at-wall-street-zen-2026-09-27/
Humana surges: Barclays bets big on Medicare star ratings rebound
September 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/humana-surges-barclays-bets-big-185942718.html
Humana Inc. stock outperforms competitors on strong trading day
September 26, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/humana-inc-stock-outperforms-competitors-on-strong-trading-day/ar-AA2cYQXD
Humana Shares Rise After Barclays Upgrade
September 25, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/humana-shares-rise-barclays-upgrade-192927019.html
Humana stock jumps. Why it could be a big winner in next Medicare star ratings.
September 25, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/humana-stock-jumps-why-it-could-be-a-big-winner-in-next-medicare-star-ratings/ar-AA2cZ1s1
Humana (NYSE:HUM) Stock Jumps 6.8% - Here's Why
September 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-humana-nyse-hum-stock-jumps-68-heres-why-2026-09-25/

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVS Health stock logo

CVS Health NYSE:CVS

$86.75 +1.55 (+1.82%)
As of 10:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Humana stock logo

Humana NYSE:HUM

$381.71 +2.03 (+0.53%)
As of 10:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas